Stay updated on Expanded Access of Lifileucel in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.

Latest updates to the Expanded Access of Lifileucel in Melanoma: Clinical Trial page
- Check5 days agoChange DetectedThe study’s listed locations were updated, including adding additional participating centers such as South Austin Medical Center, Vanderbilt University, SCRI Oncology Partners, and others, along with changes to the displayed total number of U.S. locations. The page also shows updated record dates (e.g., last update submitted/posted) accompanying the location changes.SummaryDifference3%

- Check12 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedA new page revision, v3.5.0, has been added and the previous revision, v3.4.3, removed.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.3 was added. Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check76 days agoChange DetectedA new Revision: v3.4.2 entry was added; the previous funding notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check84 days agoChange DetectedNotice: a general funding-status banner and a new version identifier (Revision: v3.4.1) were added; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Expanded Access of Lifileucel in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.